⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30672816 | 0.69 | — | — | |
| SCHEMBL1177955 | 0.61 | — | — | |
| SCHEMBL7398587 | 0.59 | — | — | |
| SCHEMBL277059 | 0.57 | — | — | |
| SCHEMBL9396453 | 0.57 | — | — | |
| SCHEMBL688972 | 0.57 | — | — | |
| SCHEMBL11409247 | 0.57 | — | — | |
| SCHEMBL1193576 | 0.57 | — | — | |
| SCHEMBL31474437 | 0.56 | — | — | |
| Hydrochloric Acid SCHEMBL30549335 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108697794-A | Combination of C-MET inhibitors and anti-PD-1 antibody molecules and uses thereof | 诺华股份有限公司 | 2018-10-23 | — | — | CN | disclosed |